Max Robotics — Global Service Robot Directory + US Certification

About

Alexander L. Antaris is pioneering the next generation of precision surgical tools, with his research squarely focused on fluorescence-guided surgery (FGS) and the development of targeted molecular imaging agents. His most impactful contribution is the design of "AND-gate" contrast agents, a sophisticated approach that activates fluorescence only in the presence of two specific biological triggers, dramatically improving the signal-to-noise ratio for enhanced tumor detection during surgery—a concept detailed in his highly cited 2020 paper (139 citations). Antaris has successfully translated this work from bench to bedside, leading the first-in-human evaluation of a prostate-specific membrane antigen (PSMA)-targeted near-infrared dye for identifying high-risk prostate cancer during robotic-assisted prostatectomy (2023, 35 citations). This landmark study demonstrated the clinical safety and efficacy of his approach for real-time, fluorescence-based identification of malignant tissue. Beyond oncology, he has also advanced nerve-specific probes, developing clinically translatable formulation strategies for systemic administration of fluorophores like LGW01-08 to prevent accidental nerve damage during surgery (2021). By bridging chemistry, imaging, and clinical application, Antaris is fundamentally reshaping how surgeons visualize pathology, directly improving patient outcomes through enhanced intraoperative decision-making.